Anxo Pharmaceutical Co - Stock

Anxo Pharmaceutical Co ROA 2024

Anxo Pharmaceutical Co ROA

-0.01

Ticker

6677.TWO

ISIN

TW0006677008

In 2024, Anxo Pharmaceutical Co's return on assets (ROA) was -0.01, a -163.47% increase from the 0.01 ROA in the previous year.

Anxo Pharmaceutical Co Aktienanalyse

What does Anxo Pharmaceutical Co do?

Anxo Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Anxo Pharmaceutical Co's Return on Assets (ROA)

Anxo Pharmaceutical Co's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Anxo Pharmaceutical Co's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Anxo Pharmaceutical Co's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Anxo Pharmaceutical Co’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Anxo Pharmaceutical Co Stock

What is the Return on Assets (ROA) of Anxo Pharmaceutical Co this year?

The Return on Assets (ROA) of Anxo Pharmaceutical Co is -0.01 undefined this year.

What was the ROA of Anxo Pharmaceutical Co compared to the previous year?

The ROA of Anxo Pharmaceutical Co has increased by -163.47% compared to the previous year.

What consequences do high ROA have for investors of Anxo Pharmaceutical Co?

A high ROA is advantageous for investors of Anxo Pharmaceutical Co, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Anxo Pharmaceutical Co?

A low ROA can be unfavorable for investors of Anxo Pharmaceutical Co as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Anxo Pharmaceutical Co affect the company?

An increase in ROA of Anxo Pharmaceutical Co can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Anxo Pharmaceutical Co impact the company?

A reduction in the ROA of Anxo Pharmaceutical Co can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Anxo Pharmaceutical Co?

Some factors that can influence the ROA of Anxo Pharmaceutical Co include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Anxo Pharmaceutical Co important for investors?

The ROA of Anxo Pharmaceutical Co is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Anxo Pharmaceutical Co take to improve ROA?

To improve ROA, Anxo Pharmaceutical Co can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Anxo Pharmaceutical Co pay?

Over the past 12 months, Anxo Pharmaceutical Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Anxo Pharmaceutical Co is expected to pay a dividend of 0 TWD.

What is the dividend yield of Anxo Pharmaceutical Co?

The current dividend yield of Anxo Pharmaceutical Co is .

When does Anxo Pharmaceutical Co pay dividends?

Anxo Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Anxo Pharmaceutical Co?

Anxo Pharmaceutical Co paid dividends every year for the past 0 years.

What is the dividend of Anxo Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 0 TWD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Anxo Pharmaceutical Co located?

Anxo Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Anxo Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Anxo Pharmaceutical Co from 6/17/2024 amounting to 0 TWD, you needed to have the stock in your portfolio before the ex-date on 6/17/2024.

When did Anxo Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 6/17/2024.

What was the dividend of Anxo Pharmaceutical Co in the year 2023?

In the year 2023, Anxo Pharmaceutical Co distributed 0 TWD as dividends.

In which currency does Anxo Pharmaceutical Co pay out the dividend?

The dividends of Anxo Pharmaceutical Co are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Anxo Pharmaceutical Co

Our stock analysis for Anxo Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Anxo Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.